Candel Therapeutics (CADL) Revenue (2020 - 2022)

Candel Therapeutics (CADL) reported Revenue of $31000.0 for Q4 2022, up 416.67% on a YoY basis from $6000.0 in Q4 2021, and little changed sequentially from $31000.0 in Q3 2022.

Candel Therapeutics (CADL) Revenue (2020 - 2022) Analysis & Trends

Candel Therapeutics (CADL) has 3 years of Revenue data on file, last reported at $31000.0 in Q4 2022.

  • For the quarter ending Q4 2022, Revenue rose 416.67% year-over-year to $31000.0; the trailing twelve-month figure through Dec 2022 stood at $124000.0 (up 25.25% YoY), and the FY2022 full-year result was $125000.0, up 25.0% from the prior year.
  • Revenue was little changed at $31000.0 in Q4 2022, from $31000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $31000.0 in Q2 2020 to a low of $6000.0 in Q4 2021.
  • A 3-year average of $28727.3 and a median of $31000.0 in 2020 frame the typical range for Revenue.
  • Across the five-year window, Revenue slumped 80.65% in 2021 and surged 416.67% in 2022, its largest moves.
  • Tracing CADL's Revenue over 3 years: stood at $31000.0 in 2020, then tumbled by 80.65% to $6000.0 in 2021, then surged by 416.67% to $31000.0 in 2022.
  • Business Quant data shows CADL's Revenue at $31000.0 in Q4 2022, $31000.0 in Q3 2022, and $31000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Candel Therapeutics 504.70 Mn 504.70 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 31,000.00
Sep 30, 2022 31,000.00
Jun 30, 2022 31,000.00
Mar 31, 2022 31,000.00
Dec 31, 2021 6,000.00
Sep 30, 2021 31,000.00
Jun 30, 2021 31,000.00
Mar 31, 2021 31,000.00
Dec 31, 2020 31,000.00
Sep 30, 2020 31,000.00
Jun 30, 2020 31,000.00